These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30373636)

  • 1. Outcomes, Interventions and Funding in Randomised Research Published in High-Impact Journals.
    Grey P; Grey A; Bolland MJ
    Trials; 2018 Oct; 19(1):592. PubMed ID: 30373636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study.
    Falk Delgado A; Falk Delgado A
    Trials; 2017 Jul; 18(1):354. PubMed ID: 28747226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysis.
    Falk Delgado A; Falk Delgado A
    Trials; 2017 Mar; 18(1):125. PubMed ID: 28292317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
    Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
    Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I
    Trials; 2011 Feb; 12():58. PubMed ID: 21356072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study.
    Lundh A; Barbateskovic M; Hróbjartsson A; Gøtzsche PC
    PLoS Med; 2010 Oct; 7(10):e1000354. PubMed ID: 21048986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
    Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
    Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industry sponsorship and authorship of clinical trials over 20 years.
    Buchkowsky SS; Jewesson PJ
    Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Industry sponsorship and positive outcome in vascular and endovascular randomised trials.
    Hajibandeh S; Hajibandeh S; Antoniou SA; Antoniou GA; Torella F
    Vasa; 2017 Jan; 46(1):67-68. PubMed ID: 27889961
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of industry collaboration on randomised controlled trials in oncology.
    Linker A; Yang A; Roper N; Whitaker E; Korenstein D
    Eur J Cancer; 2017 Feb; 72():71-77. PubMed ID: 28027518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes.
    Nkansah N; Nguyen T; Iraninezhad H; Bero L
    Public Health Nutr; 2009 Oct; 12(10):1931-7. PubMed ID: 19254426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial sponsorship and self-reported conflicts of interest in breast cancer radiation therapy: An analysis of prospective clinical trials.
    Leite ETT; Moraes FY; Marta GN; Taunk NK; Vieira MTL; Hanna SA; Silva JLF; Carvalho HA
    Breast; 2017 Jun; 33():29-33. PubMed ID: 28273553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
    Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I
    Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.
    Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP
    J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Funding source and the quality of reports of chronic wounds trials: 2004 to 2011.
    Hodgson R; Allen R; Broderick E; Bland JM; Dumville JC; Ashby R; Bell-Syer S; Foxlee R; Hall J; Lamb K; Madden M; O'Meara S; Stubbs N; Cullum N
    Trials; 2014 Jan; 15():19. PubMed ID: 24422753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design.
    Goswami ND; Tsalik EL; Naggie S; Miller WC; Horton JR; Pfeiffer CD; Hicks CB
    Trials; 2014 Jan; 15():31. PubMed ID: 24450313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantity, topics, methods and findings of randomised controlled trials published by German university departments of general practice - systematic review.
    Heinmüller S; Schneider A; Linde K;
    Trials; 2016 Apr; 17(1):211. PubMed ID: 27107809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of industry sponsorship and positive outcome in randomised controlled trials in general and abdominal surgery: protocol for a systematic review and empirical study.
    Probst P; Grummich K; Ulrich A; Büchler MW; Knebel P; Diener MK
    Syst Rev; 2014 Nov; 3():138. PubMed ID: 25431307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between funding by commercial interests and study outcome in randomized controlled drug trials.
    Yaphe J; Edman R; Knishkowy B; Herman J
    Fam Pract; 2001 Dec; 18(6):565-8. PubMed ID: 11739337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.